导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -9.98% | 816/1025 |
| 近一周 | -1.99% | 793/1074 |
| 近一月 | -4.58% | 396/1073 |
| 近一季 | 6.39% | 121/1065 |
| 近半年 | -8.14% | 727/1049 |
| 近一年 | -18.75% | 859/995 |
| 近两年 | 7.12% | 835/906 |
| 近三年 | -33.21% | 797/814 |
| 成立以来 | 293.32% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.57% 847/1070 |
-12.32% 969/1101 |
- - |
- - |
| 2025 | -6.16% 950/1065 |
-0.94% 855/1014 |
-2.36% 863/1038 |
4.60% 942/1050 |
-7.25% 811/1065 |
| 2024 | -13.03% 823/1011 |
-4.34% 547/960 |
-15.74% 947/983 |
14.23% 281/991 |
-5.53% 698/1011 |
| 2023 | -16.65% 585/952 |
2.75% 466/880 |
-9.80% 761/895 |
-1.18% 123/915 |
-9.00% 813/952 |
| 2022 | -7.71% 57/867 |
-19.44% 488/773 |
21.58% 16/806 |
-11.44% 340/845 |
6.41% 153/867 |
| 2021 | 3.98% 317/740 |
2.39% 82/580 |
12.50% 296/659 |
-14.22% 591/704 |
5.24% 213/740 |
| 2020 | 103.24% 24/554 |
-4.35% 269/419 |
39.37% 30/466 |
18.38% 75/517 |
28.80% 42/554 |
| 2019 | 35.63% 257/410 |
29.85% 384/1149 |
0.35% 295/1231 |
0.27% 326/390 |
3.80% 366/410 |
| 2018 | -14.00% 21/349 |
- - |
- - |
- - |
-11.78% 526/1080 |
| 2017 | 28.24% 47/285 |
- - |
- - |
- - |
- - |
| 2016 | 2.14% 25/205 |
- - |
- - |
- - |
- - |
| 2015 | 32.41% 46/151 |
- - |
- - |
- - |
- - |
| 2014 | 35.57% 5/24 |
- - |
- - |
- - |
- - |
| 2013 | 1.39% 17/21 |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票C | 0.8165 | 61.04% |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商医药健康产业股票 | 2.6450 | 53.78% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 嘉实医疗保健股票 | 2.6190 | 42.34% |
| 前海开源公共卫生股票C | 0.4647 | 42.24% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 广发医药精选股票C | 1.3103 | 40.86% |
| 交银医药创新股票C | 3.0948 | 37.26% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银消费新驱动股票 VS. 东吴新产业精选股票A(580008) |